Associated Papers
Case report: Complete response of an anaplastic thyroid carcinoma patient with NRAS Q61R/BRAF D594N mutations to the triplet of dabrafenib, trametinib and PD-1 antibody.
Gui L et al.
Frontiers in Immunology, 2023
Select a paper to view details